Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BL.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.10.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DH.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
DH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XGEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.54EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.54EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.52EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.11.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used